...
首页> 外文期刊>Gut: Journal of the British Society of Gastroenterology >Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma
【24h】

Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma

机译:综合表征与胰腺导管腺癌相关的舱室特异性长非编码RNA

获取原文
获取原文并翻译 | 示例
           

摘要

Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease with limited therapeutic options. Genome and transcriptome analyses have identified signalling pathways and cancer driver genes with implications in patient stratification and targeted therapy. However, these analyses were performed in bulk samples and focused on coding genes, which represent a small fraction of the genome.We developed a computational framework to reconstruct the non-coding transcriptome from cross-sectional RNA-Seq, integrating somatic copy number alterations (SCNA), common germline variants associated to PDA risk and clinical outcome. We validated the results in an independent cohort of paired epithelial and stromal RNA-Seq derived from laser capture microdissected human pancreatic tumours, allowing us to annotate the compartment specificity of their expression. We employed systems and experimental biology approaches to interrogate the function of epithelial long non-coding RNAs (lncRNAs) associated with genetic traits and clinical outcome in PDA.We generated a catalogue of PDA-associated lncRNAs. We showed that lncRNAs define molecular subtypes with biological and clinical significance. We identified lncRNAs in genomic regions with SCNA and single nucleotide polymorphisms associated with lifetime risk of PDA and associated with clinical outcome using genomic and clinical data in PDA. Systems biology and experimental functional analysis of two epithelial lncRNAs (Our findings indicate that lncRNAs are associated with genetic marks of pancreatic cancer risk, contribute to the transcriptional regulation of neoplastic cells and provide an important resource to design functional studies of lncRNAs in PDA.
机译:胰腺导管腺癌(PDA)是一种高度转移性的治疗选择。基因组和转录组分析已鉴定了患者分层和靶向治疗的影响的信号传导途径和癌症驾驶基因。然而,这些分析在批量样品中进行并重注于代表基因组的一小部分的编码基因。我们开发了一种计算框架,以从横截面RNA-SEQ重建非编码转录组,整合体细胞拷贝数改变( SCNA),与PDA风险和临床结果相关的常见种系变体。我们验证了源自激光捕获微小人胰腺肿瘤的独立成对上皮和基质RNA-SEQ的独立队列的结果,使我们能够注释其表达的舱室特异性。我们使用的系统和实验生物学方法来询问与PDA相关的遗传性状性状和临床结果相关的上皮长期非编码RNA(LNCRNA)的功能.WE产生了PDA相关的LNCRNA的目录。我们表明,LNCRNA定义了具有生物学和临床意义的分子亚型。我们在具有与PDA的寿命风险相关的基因组区域中鉴定了基因组区域中的LNCRNA,并使用PDA中使用基因组和临床数据与临床结果相关的临床结果。两种上皮LNCRNA的系统生物学和实验功能分析(我们的研究结果表明,LNCRNA与胰腺癌风险的遗传分数相关,有助于肿瘤细胞的转录调节,并提供了PDA中LNCRNA的功能研究的重要资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号